Commercial astronauts shed light on flights' health impacts

Short-term space travel causes many of the same molecular and physiologic changes as long-term space missions, but most reverse within months of returning to Earth. Yet, those changes that are longer-lasting and distinct between crew members reveal new targets for aerospace medicine and can guide new missions, according to the results of a massive international research endeavor by investigators at Weill Cornell Medicine, SpaceX, and other organizations.

Related Keywords

Japan , Japanese , Jangkeun Kim , Scott Kelly , Richard Granstein , Susan Bailey , Kirill Grigorev , Nadia Houerbi , Weill Cornell , Christopher Mason , Afshin Beheshti , David Lyden , Jared Isaacman , Cem Meydan , Braden Tierney , Eliahg Overbey , Theodore Nelson , Chris Sembroski , Haley Arseneaux , Eliah Overbey , European Space Agency , Aerospace Medicine Biobank , Broad Institute , Min Yu At University Of Maryland , Xiao Vivian Mao At Loma Linda University , Japanese Aerospace Exploration Agency , University Of Austin , Spacex , Edward Meyer Cancer Center , National Aeronautics , Space Administration , Research Institute , Mason Lab , Sian Proctor , Weill Cornell Medicine , Worldquant Professor , Computational Biomedicine , Space Omics , Medical Atlas , Feil Family Brain , Mind Research Institute , Worldquant Initiative , Quantitative Prediction , Ari Melnick , Iwijn De Vlaminck , International Space Station , Jiwoon Park , Irina Matei , Loma Linda University , Second Space Age , Aerospace Medicine ,